Spectrum Pharmaceuticals, Inc. (SPPI) News

Spectrum Pharmaceuticals, Inc. (SPPI): $0.95

-0.06 (-5.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SPPI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 461

in industry

Filter SPPI News Items

SPPI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SPPI News Highlights

  • SPPI's 30 day story count now stands at 4.
  • Over the past 15 days, the trend for SPPI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • ACT, LAW and SRTS are the most mentioned tickers in articles about SPPI.

Latest SPPI News From Around the Web

Below are the latest news stories about Spectrum Pharmaceuticals Inc that investors may wish to consider to help them evaluate SPPI as an investment opportunity.

Analysts Offer Insights on Healthcare Companies: Spectrum Pharmaceuticals (SPPI), Sensus Healthcare (SRTS) and Verona Pharma (VRNA)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Spectrum Pharmaceuticals (SPPI – Research Report), Sensus Healthcare (SRTS – Research Report) and Verona Pharma (VRNA – Research Report) with bullish sentiments. Spectrum Pharmaceuticals (SPPI) In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Spectrum Pharmaceuticals, with a price target of $10.00. The company's shares closed last Wednesday at $1.27. According to TipRanks.com, White is a 4-star analyst with an average return of -22.1% and a 20.5% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Aquestive Therapeutics, Oncternal Therapeutics, and Inovio Pharmaceuticals.

Christine Brown on TipRanks | January 6, 2022

Spectrum Pharmaceuticals Announces Strategic Restructuring

HENDERSON, Nev., January 05, 2022--Spectrum Pharmaceuticals Announces Strategic Restructuring

Yahoo | January 5, 2022

Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical

HENDERSON, Nev., January 04, 2022--Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical

Yahoo | January 4, 2022

SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders

SAN DIEGO, CA / ACCESSWIRE / December 22, 2021 / Shareholder rights law firm Robbins LLP is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to determine whether certain Spectrum officers and directors violated the Securities Exchange Act of 1934 and breached fiduciary duties to shareholders.

Yahoo | December 22, 2021

Did You Acquire (SPPI) Before December 27, 2018? Should Spectrum Pharmaceuticals Management be Held Accountable for Investors Losses? Contact Johnson Fistel

SAN DIEGO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ: SPPI) against certain of its officers and directors. Recently, a class action complaint was filed against Spectrum. According to the Complaint, the Company made false and misleading statements to the market. Spectrum's manufacturing facility for ROLONTIS failed to maintain appropriate controls and procedures. These d

Yahoo | December 15, 2021

Do Options Traders Know Something About Spectrum Pharmaceuticals (SPPI) Stock We Don't?

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Yahoo | December 10, 2021

Analysts’ Top Healthcare Picks: Anavex Life Sciences (AVXL), Spectrum Pharmaceuticals (SPPI)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Anavex Life Sciences (AVXL – Research Report) and Spectrum Pharmaceuticals (SPPI – Research Report) with bullish sentiments. Anavex Life Sciences (AVXL) In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Anavex Life Sciences, with a price target of $50.00. The company's shares closed last Tuesday at $18.02. According to TipRanks.

Catie Powers on TipRanks | December 7, 2021

SPPI Stock: More Upside For Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI)?

In the last trading session, 3.54 million Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares changed hands as the companys beta touched 1.90. With the companys per share price at $1.37 changed hands at -$0.21 or -13.29% during last session, the market valuation stood at $259.09M. SPPIs last price was a discount, traded about -282.48% off its 52-week SPPI Stock: More Upside For Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI)? Read More »

Marketing Sentinel | December 6, 2021

Down 38% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI)

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Yahoo | December 6, 2021

Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib

HENDERSON, Nev., December 06, 2021--Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib

Yahoo | December 6, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.64 seconds.